These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27748883)

  • 1. Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells.
    Lu X; Guo H; Chen X; Xiao J; Zou Y; Wang W; Chen Q
    Oncol Rep; 2016 Dec; 36(6):3105-3112. PubMed ID: 27748883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
    Ko H
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoC is essential in TGF-β1 induced epithelial-mesenchymal transition in cervical cancer cells.
    He X; Qian Y; Cai H; Yang S; Cai J; Wang Z
    Oncol Lett; 2015 Aug; 10(2):985-989. PubMed ID: 26622610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
    Kim J; Hwan Kim S
    PLoS One; 2013; 8(9):e74342. PubMed ID: 24023938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition.
    Zhang HJ; Wang HY; Zhang HT; Su JM; Zhu J; Wang HB; Zhou WY; Zhang H; Zhao MC; Zhang L; Chen XF
    Mol Cell Biochem; 2011 Sep; 355(1-2):309-14. PubMed ID: 21695462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinnamomum cassia extracts reverses TGF-β1-induced epithelial-mesenchymal transition in human lung adenocarcinoma cells and suppresses tumor growth in vivo.
    Lin CY; Hsieh YH; Yang SF; Chu SC; Chen PN; Hsieh YS
    Environ Toxicol; 2017 Jul; 32(7):1878-1887. PubMed ID: 28258635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBI-1 inhibits epithelial-to-mesenchymal transition, migration, and invasion in lung adenocarcinoma A549 cells by downregulating transforming growth factor-β1 signaling pathway.
    Lim W; Jeon BN; Kim YJ; Kim KH; Ko H
    J Cell Biochem; 2022 Mar; 123(3):644-656. PubMed ID: 34989006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
    Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
    BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
    Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
    J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
    Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells.
    Gou WF; Zhao Y; Lu H; Yang XF; Xiu YL; Zhao S; Liu JM; Zhu ZT; Sun HZ; Liu YP; Xu F; Takano Y; Zheng HC
    BMC Cancer; 2014 Jul; 14():477. PubMed ID: 24986540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line.
    Ren J; Wang R; Huang G; Song H; Chen Y; Chen L
    Cancer Biother Radiopharm; 2013 Sep; 28(7):565-71. PubMed ID: 23802127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
    Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
    Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
    Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
    Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.